The Impact of Door to Diuretic Time in Acute Heart Failure on Hospital Length of Stay and In-Patient Mortality

被引:4
作者
Iqbal, Arshad Muhammad [1 ,2 ]
Mohammed, Sohaib K. [3 ]
Zubair, Nida [4 ,5 ]
Mubarik, Ateeq [6 ,7 ,8 ]
Ahmed, Adnan [9 ]
Jamal, Syed Farrukh [10 ]
Hassan, Syed Moin [11 ]
Haq, Furqan [12 ]
Muddassir, Salman [1 ]
机构
[1] Univ South Florid, Morsani Coll Med Grad Med Educ GME, Oak Hill Hosp, Internal Med, Brooksville, FL 34601 USA
[2] Univ Missouri, Sch Med, Cardiol Electrophysiol, Columbia, MO 65212 USA
[3] Deccan Coll Med Sci, Internal Med, Hyderabad, India
[4] Dow Med Coll, Internal Med, Karachi, Pakistan
[5] Civil Hosp, Karachi, Pakistan
[6] Oak Hill Hosp, Internal Med, Brooksville, FL USA
[7] New York Sleep Disorder Ctr, Sleep Med, Brooksville, FL USA
[8] Ascension St Michaels Hosp, Internal Med, Stevens Point, WI USA
[9] St Joseph Hosp, Internal Med, Chicago, IL USA
[10] Cleveland Clin Abu Dhabi, Cardiol, Abu Dhabi, U Arab Emirates
[11] North Shore Med Ctr, Internal Med, Salem, MA USA
[12] Hosp Corp Amer West Florida, Miscellaneous, Tampa, FL USA
关键词
door to diuretic time; acute decompensated heart failure; mortality; length of hospital stay (los);
D O I
10.7759/cureus.12742
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Acute heart failure (AHF) can be life-threatening if not treated promptly and can significantly increase the number of annual emergency department (ED) encounters in the United States. Achieving adequate and prompt euvolemic state in AHF patients using intravenous (IV) diuretics is the cornerstone of treatment, which not only reduces in-hospital stay and mortality but also decreases healthcare expenditures. Surprisingly, the door to diuretic (D2D) time in AHF patients has always been a debatable issue among physicians worldwide, and so far, there are no set guidelines. This study examines a large cohort of AHF patients to determine the association between diuretics use within 90 minutes of ED admission and hospital length of stay (LOS) and patient mortality. Methods Retrospective institutional data of AHF patients receiving IV diuretics following ED admission were extracted from 2016 to 2017. A total of 7,751 patients treated for AHF exacerbation were included, which were further divided into two groups based on the timing of diuretics administration (<90 minutes vs. >= 90 minutes). The primary outcomes were LOS between the two groups and hospital mortality. The standard statistical methodology was used for data analysis. Results A total of 7,751 AHF cases receiving IV diuretics were identified. Almost 1,432 patients (18.5%) received IV diuretics within 90 minutes of ER admission (group 1) while 6,319 patients (81.5%) patients received IV diuretics after 90 minutes (group 2). Furthermore, among group 1 patients, average LOS was noted to be associated with shorter hospitalization (average of 1.423 days less as compared to group 2 patients (confidence interval (CI) =1.02-1.82; p<0.05). Finally, after controlling for other mortality risk factors, patients in group 2 were 1.435 times more likely to have died compared to patients in group 1 (CI=1.03-1.98; p<0.05). Conclusions D2D time in AHF patients has always been a crucial judgmental decision. The current study successfully demonstrated the relation between IV diuretics administration within 90 minutes of ED admission, favorable clinical outcomes, and decreased mortality rates. More adequately powered studies are needed to validate the results of our current study further.
引用
收藏
页数:8
相关论文
共 13 条
[1]   National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008 [J].
Chen, Jersey ;
Normand, Sharon-Lise T. ;
Wang, Yun ;
Krumholz, Harlan M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (15) :1669-1678
[2]   Increased mortality after an acute heart failure episode: New pathophysiological insights from the RELAX-AHF study and beyond [J].
Cotter G. ;
Milo O. ;
Davison B.A. .
Current Heart Failure Reports, 2014, 11 (1) :19-30
[3]   Improving care for patients with acute heart failure: before, during and after hospitalization [J].
Cowie, Martin R. ;
Anker, Stefan D. ;
Cleland, John G. F. ;
Felker, G. Michael ;
Filippatos, Gerasimos ;
Jaarsma, Tiny ;
Jourdain, Patrick ;
Knight, Eve ;
Massie, Barry ;
Ponikowski, Piotr ;
Lopez-Sendon, Jose .
ESC HEART FAILURE, 2014, 1 (02) :110-145
[5]   THE IMPACT OF DOOR TO DIURETIC TIME IN ACUTE HEART FAILURE ON HOSPITAL LENGTH OF STAY AND INPATIENT MORTALITY [J].
Iqbal, Arshad Muhammad ;
Hassan, Syed Moin ;
Siddiqui, Salaah ;
Mubarik, Ateeq ;
Ali, Muhammad Zeeshan ;
Haq, Furqan ;
Waheed, Abdul ;
Muddassir, Salman .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) :838-838
[6]   Acute Heart Failure: Definition, Classification and Epidemiology [J].
Kurmani S. ;
Squire I. .
Current Heart Failure Reports, 2017, 14 (5) :385-392
[7]   Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure - An ADHERE (Acute Decompensated Heart Failure National Registry) analysis [J].
Maisel, Alan S. ;
Peacock, William F. ;
McMullin, N. ;
Jessie, Robert ;
Fonarow, Gregg C. ;
Wynne, Janet ;
Mills, Roger M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (07) :534-540
[8]   Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure [J].
Matsue, Yuya ;
Damman, Kevin ;
Voors, Adriaan A. ;
Kagiyama, Nobuyuki ;
Yamaguchi, Tetsuo ;
Kuroda, Shunsuke ;
Okumura, Takahiro ;
Kida, Keisuke ;
Mizuno, Atsushi ;
Oishi, Shogo ;
Inuzuka, Yasutaka ;
Akiyama, Eiichi ;
Matsukawa, Ryuichi ;
Kato, Kota ;
Suzuki, Satoshi ;
Naruke, Takashi ;
Yoshioka, Kenji ;
Miyoshi, Tatsuya ;
Baba, Yuichi ;
Yamamoto, Masayoshi ;
Murai, Koji ;
Mizutani, Kazuo ;
Yoshida, Kazuki ;
Kitai, Takeshi .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (25) :3042-3051
[9]   ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC [J].
McMurray, John J. V. ;
Adamopoulos, Stamatis ;
Anker, Stefan D. ;
Auricchio, Angelo ;
Boehm, Michael ;
Dickstein, Kenneth ;
Falk, Volkmar ;
Filippatos, Gerasimos ;
Fonseca, Candida ;
Angel Gomez-Sanchez, Miguel ;
Jaarsma, Tiny ;
Kober, Lars ;
Lip, Gregory Y. H. ;
Maggioni, Aldo Pietro ;
Parkhomenko, Alexander ;
Pieske, Burkert M. ;
Popescu, Bogdan A. ;
Ronnevik, Per K. ;
Rutten, Frans H. ;
Schwitter, Juerg ;
Seferovic, Petar ;
Stepinska, Janina ;
Trindade, Pedro T. ;
Voors, Adriaan A. ;
Zannad, Faiez ;
Zeiher, Andreas ;
Bax, Jeroen J. ;
Baumgartner, Helmut ;
Ceconi, Claudio ;
Dean, Veronica ;
Deaton, Christi ;
Fagard, Robert ;
Funck-Brentano, Christian ;
Hasdai, David ;
Hoes, Arno ;
Kirchhof, Paulus ;
Knuuti, Juhani ;
Kolh, Philippe ;
McDonagh, Theresa ;
Moulin, Cyril ;
Popescu, Bogdan A. ;
Reiner, Zeljko ;
Sechtem, Udo ;
Sirnes, Per Anton ;
Tendera, Michal ;
Torbicki, Adam ;
Vahanian, Alec ;
Windecker, Stephan ;
McDonagh, Theresa ;
Sechtem, Udo .
EUROPEAN HEART JOURNAL, 2012, 33 (14) :1787-1847
[10]  
Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350